| News

Synendos raises 20 million Swiss francs

12.11.2020

Synendos Therapeutics has concluded a Series A financing round, raising 20 million Swiss francs. The Basel biotech will use the funds to advance the pre-clinical research on molecules for treating anxiety-related conditions. Synendos was supported by BaseLaunch, the accelerator and incubator of Basel Area Business & Innovation.

Andrea Chicca. CEO of Synendos Therapeutics, based in the Switzerland Innovation Park Basel Area in Allschwil

Synendos Therapeutics is developing a new class of small molecules aimed at restoring the natural functioning of the endocannabinoid system in the brain. This has the potential for treating a wide range of anxiety, mood and stress-related disorders. According to a press release, the 20 million francs raised in the Series A financing will allow Synendos Therapeutics to complete pre-clinical development on these molecules. In achieving this success, the startup was supported by BaseLaunch, the accelerator and incubator of Basel Area Business & Innovation, the investment and innovation promotion agency. As a result, Synendos has received key early stage financial and operational support in the early development of the company.

“Raising institutional financing is always challenging but doing so in the middle of a global pandemic is truly an extraordinary achievement,” said  Stephan Emmerth, Director Therapeutic Innovation and BaseLaunch. “So, a big congratulation to the team of Synendos on this important step towards developing game changing treatments for patients suffering from neuropsychiatric disorders.” BaseLaunch members have received investment of over 180 million francs overall.

The financing round was led by Kurma Partners and Sunstone Life Science Ventures. Other investors included Bernina Bio Invest, Schroder Adveq, High-Tech Gründerfonds, Lichtsteiner Foundation, Essential Investments, Zürcher Kantonalbank and private investors. Their investment will allow Synendos to complete pre-clinical development and progress lead candidate through proof of concept clinical study. Representatives from Kurma, Sunstone and Benina Bio Invest will also be joining the Synendos Board of Directors.

Synendos Therapeutics is based in the Switzerland Innovation Park Basel Area in Allschwil.

Share this article

Sign up to receive our newsletter in your inbox.

You may also be interested in

Ontotext opens new office in the Basel Area
Basel Area Business & Innovation, Innovation, Invest, Switzerland Innovation Park

Ontotext opens new office in the Basel Area

Ontotext, a company based in New York City and the Bulgarian capital of Sofia, has opened a new location at...

Read More
The gravitational attraction of the Basel Area – Europe’s leading healthcare hub.
Basel Area Business & Innovation, Innovation, Invest

The gravitational attraction of the Basel Area – Europe’s leading healthcare hub.

Breakthrough advances in digital technology and artificial intelligence are transforming how we manage our health, and helping data-driven life science...

Read More
Owkin heads to Basel
Basel Area Business & Innovation, Innovation, Invest

Owkin heads to Basel

The Franco-US startup Owkin is establishing a branch office in Basel. The company develops solutions for the life sciences industry...

Read More
Danish AI company settling in the Basel Area
Basel Area Business & Innovation, Innovation, Invest, Switzerland Innovation Park

Danish AI company settling in the Basel Area

Abzu has settled on the Novartis Campus of the Switzerland Innovation Park Basel Area. From there, the Danish deep tech...

Read More
«I always wanted to create something from scratch»
Basel Area Business & Innovation, Innovation, Invest, Switzerland Innovation Park

«I always wanted to create something from scratch»

Already when he was young, he was driven to create and invent. Today at the age of 33, Gwenael Hannema...

Read More
The i4Challenge announces the winners of 2021
Basel Area Business & Innovation, Innovation

The i4Challenge announces the winners of 2021

The i4Challenge shines a light on companies and innovators who help to facilitate the industrial transformation. We present the winners...

Read More
1 2 3 49

Do you have a question? We'd like to hear from you.